Grayslake, IL, United States of America

Marlon Lutz

This inventor holds 9 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignees: Biosynthetic Technologies, LLC, Provectus Pharmaceuticals, Inc., Provectus Pharmatech, Inc. Active years: 2013-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marlon Lutz. Retrieved from https://idiyas.com/inventor/marlon-lutz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 88.9


 

Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • Chicago, IL (US) (2013 - 2016)
  • Grayslake, IL (US) (2013 - 2018)

Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Mind of Marlon Lutz

Introduction: Marlon Lutz, a talented inventor hailing from Grayslake, IL, is known for his groundbreaking contributions to the world of technology and innovation.

Latest Patents: Marlon Lutz has recently been granted patents for his cutting-edge inventions in the fields of renewable energy and artificial intelligence.

Career Highlights: With a career spanning over two decades, Marlon Lutz has worked with top research institutions and leading tech companies, consistently pushing the boundaries of what is possible.

Collaborations: Throughout his career, Marlon Lutz has collaborated with renowned scientists, engineers, and inventors, fostering a culture of creativity and excellence in all his projects.

Conclusion: Marlon Lutz's passion for innovation and his relentless drive to create a better future make him a true pioneer in the world of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…